Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Decker

Showing results (11-20 of 180) with videos related to

Pageof 18
Sort By:
Chemmedchem|March 31, 2015
New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compoundsMartin Nimczick, Michael Decker
Expert Opinion on Therapeutic Patents|December 15, 2016
Bitopic muscarinic agonists and antagonists and uses thereof: a patent evaluation of US20160136145A1Ulrike Holzgrabe, Michael Decker
Chempluschem|June 30, 2020
Development and Biological Applications of Fluorescent Opioid LigandsAntonios Drakopoulos, Michael Decker
Molecules (Basel, Switzerland)|December 22, 2016
Special Issue: "Molecules against Alzheimer"Michael Decker, Diego Muñoz-Torrero
Archiv Der Pharmazie|May 6, 2015
Rational Modification of the Biological Profile of GPCR Ligands through Combination with Other Biologically Active MoietiesGuozheng Huang, Martin Nimczick, Michael Decker
Bioorganic & Medicinal Chemistry|November 18, 2005
Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesteraseMichael Decker, Fabian Krauth, Jochen Lehmann
Journal of the American Dietetic Association|April 2, 2003
Secondary analysis of a marketing research database reveals patterns in dairy product purchases over timeTimothy W Van Wave, Michael Decker
Case Reports in Orthopedics|August 18, 2020
Well Leg Compartment Syndrome after Contralateral Femoral Neck ORIFChristopher Shultz, Kristen Baca, Michael Decker
Chemmedchem|June 25, 2020
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular ProbesFilippo Basagni, Michela Rosini, Michael Decker
Bioorganic & Medicinal Chemistry|March 18, 2008
Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant propertiesMichael Decker, Birgit Kraus, Jörg Heilmann
Pageof 18

Showing results (11-20 of 180) with videos related to

Sort By:
Pageof 18
Chemmedchem|March 31, 2015
New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compoundsMartin Nimczick, Michael Decker
Expert Opinion on Therapeutic Patents|December 15, 2016
Bitopic muscarinic agonists and antagonists and uses thereof: a patent evaluation of US20160136145A1Ulrike Holzgrabe, Michael Decker
Chempluschem|June 30, 2020
Development and Biological Applications of Fluorescent Opioid LigandsAntonios Drakopoulos, Michael Decker
Molecules (Basel, Switzerland)|December 22, 2016
Special Issue: "Molecules against Alzheimer"Michael Decker, Diego Muñoz-Torrero
Archiv Der Pharmazie|May 6, 2015
Rational Modification of the Biological Profile of GPCR Ligands through Combination with Other Biologically Active MoietiesGuozheng Huang, Martin Nimczick, Michael Decker
Bioorganic & Medicinal Chemistry|November 18, 2005
Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesteraseMichael Decker, Fabian Krauth, Jochen Lehmann
Journal of the American Dietetic Association|April 2, 2003
Secondary analysis of a marketing research database reveals patterns in dairy product purchases over timeTimothy W Van Wave, Michael Decker
Case Reports in Orthopedics|August 18, 2020
Well Leg Compartment Syndrome after Contralateral Femoral Neck ORIFChristopher Shultz, Kristen Baca, Michael Decker
Chemmedchem|June 25, 2020
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular ProbesFilippo Basagni, Michela Rosini, Michael Decker
Bioorganic & Medicinal Chemistry|March 18, 2008
Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant propertiesMichael Decker, Birgit Kraus, Jörg Heilmann
Pageof 18